International Federation of Clinical Chemistry and Laboratory Medicine

Disclaimer:
Information regarding a non-State actor, contained in the section “Non-State Actors Profiles” in the Register, has been provided by that non-State actor itself, and the accuracy and completeness of such information is the sole responsibility of that non-State actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State Actors in Official Relations” has been provided by WHO, subject to certain conditions. All access and use of any section of the Register is governed by the Terms and Conditions of Use.

 Overview

International Federation of Clinical Chemistry and Laboratory Medicine
IFCC
The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) was formed to advance the
excellence in laboratory medicine throughout the world in the interest of the peoples of the world.
http://www.ifcc.org
11 Oct 2021 12:51:12 PM

 General information

International Federation of Clinical Chemistry and Laboratory Medicine
IFCC
International Federation of Clinical Chemistry and Laboratory Medicine
IFCC
The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) was formed to advance the
excellence in laboratory medicine throughout the world in the interest of the peoples of the world.
c/o Seedamm Business Center, Churerstrasse, 135
Pfaeffikon
SZ
8808
Switzerland
ifcc@ifcc.org
http://www.ifcc.org

 Governance

Non Profit Organization
1952
Executive Board
Prof Khosrow Adeli
President
The Hospital for Sick Children-Toronto, ON-CA
Dr. David Kinniburgh
Secretary
University of Calgary-Alberta Centre for Toxicology-Calgary, AB-CA
Dr. Alexander Haliassos
Treasurer
Greek Proficiency Testing Scheme for Clinical Labs-Athens-GR
Mr. Joseph Passarelli
Corporate Representative
Scientific Relations Roche Diagnostics Operations-Indianapolis, IN-USA
Prof. Adekunle Bashiru Okesina
EB Reg Fed Rep - African Fed Clinical Chemistry-AFCC
Unilorin Teaching Hospital-University Ilorin-Kwara State-NG
Prof. Abderrazek Hedhili
EB Reg Fed Rep - Arab Fed Clinical Biology-AFCB
Laboratoire de Toxicologie CMYAMU-Tunis-TU
Dr. Sunil Sethi
EB Reg Fed Rep - Asia-Pacific Fed Clinical Biochemistry Lab Med-APFCB
National University Hospital-Dept Lab Med-SG
Prof. Ana-Maria Šimundić
EB Reg Fed Rep - European Fed Clinical Chemistry Lab Med-EFLM
University Hospital Sveti Duh-Zagreb-HR
Dr. Ana María Lena Rodríguez
EB Reg Fed Rep - Latin-American Confed Clinical Biochemistry -COLABIOCLI
Biochemistry Department University of Montevideo-UY
Dr. Stephen Hill
EB Reg Fed Rep - North American Fed Clinical Chemistry Lab Med-NAFCC
McMaster University-Hamilton, ON-CA
As above

IFCC Council
IFCC Full Members Societies' Representatives (actually 95)
Voting of Executive Board Members

 Financial information

January
2020
December
2020
885,000
December
2020
0
Private sector entities (including business associations)
Philanthropic foundations
NGOs, academic institutions
Government entities, intergovernmental organizations, including UN
General public, individuals
Total
54,000
54,000
106,000
106,000
390,000
195,000
585,000
45,000
45,000
95,000
95,000
690,000
195,000
885,000

 Membership

Individuals
0
0
NGOs
113
95
Private sector entities
48
48
Philanthropic foundations
0
0
Academic institutions
0
0
Government entities
0
0
Intergovernmental organizations
https://www.ifcc.org/executive-board-and-council/council/

Organizational Structure

No data available
No data available

Relations

No data available
No data available

  Activities

To:
- Advance the theory and practice of clinical laboratory science and to further its application in the provision of health services and the practice of medicine;
- Establish, inter alia, encourage and foster high professional standards of clinical laboratory science;
- Promote international cooperation and coordination in the development of clinical laboratory science in matters of research, procedures, materials, regulations and practices, education and training, codes of ethics and related subjects;
- Provide a basis for closer liaison and the free exchange of professional information among clinical laboratory scientists worldwide;
- Sponsor and support International Congresses, etc...
- Encourage, sponsor and/or conduct studies, prepare recommendations, reference measurement procedures and reference materials, reviews and reports on facets of clinical laboratory science of international interest and concern
- Assist in the organisation and establishment of new societies.
Strategic Priority 1: One billion more people benefiting from universal health coverage
Strategic Priority 2: One billion more people better protected from health emergencies
Strategic Priority 3: One billion more people enjoying better health and well-being
Strategic Priority 4: More effective and efficient WHO providing better support to countries

  Country presence

Regions
Countries
Activities
Members
Offices / representatives
African Region
Region of the Americas
Eastern Mediterranean Region
European Region
South-East Asia Region
Western Pacific Region
Global

  Disclosure & declaration

Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.

For the purposes of this statement:

  • tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
  • arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.

This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.

In view of the foregoing, please answer the following questions:

  1. Is your entity, or was your entity over the last four years, part of the tobacco or arms industries (as defined above)?
  1. To the best of your entity’s knowledge, is your entity, or has your entity over the last four years, engaged in activities that are aimed at furthering or supporting the interests of the tobacco industry? This includes, but is not limited to, supply contracts, contract work, services and lobbying.
  1. To the best of your entity’s knowledge, does your entity currently, or did your entity over the last four years, have any other association or relationship with the tobacco industry (as defined above). This includes in particular investment interests (other than general mutual funds or similar arrangements whereby your entity has no control over the selection of the investments), commercial business interests, the provision or receipt of financial and/or other support.
  1. If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.

Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.
By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.
As indicated in IFCC Statutes' preamble:
Clinical Chemistry and Laboratory Medicine involves the study and application of chemistry, biochemistry, and molecular biology to the practice of diagnosis in Medicine. The scope of the subject matter of this discipline is recognised by several names in various parts of the world (e.g. clinical biochemistry, physiological chemistry,
chemical pathology). Included in its scope are the chemical facets of all areas of laboratory medicine. The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) was formed to advance the science and practice of laboratory medicine throughout the world in the interest of the peoples of the world.
Corporate Members cooperates with IFCC offering services for the field of clinical laboratory science.